Notis-McConarty Edward’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,386
| Closed | -$229K | – | 96 |
|
|
2016
Q3 | $229K | Buy |
+3,386
| New | +$229K | 0.16% | 93 |
|
|
2016
Q2 | – | Sell |
-3,386
| Closed | -$213K | – | 95 |
|
|
2016
Q1 | $213K | Buy |
3,386
+50
| +1% | +$3.15K | 0.15% | 95 |
|
|
2015
Q4 | $314K | Buy |
3,336
+50
| +2% | +$4.71K | 0.23% | 83 |
|
|
2015
Q3 | $263K | Sell |
3,286
-50
| -1% | -$4K | 0.2% | 87 |
|
|
2015
Q2 | $400K | Hold |
3,336
| – | – | 0.27% | 78 |
|
|
2015
Q1 | $348K | Sell |
3,336
-250
| -7% | -$26.1K | 0.24% | 86 |
|
|
2014
Q4 | $348K | Sell |
3,586
-25
| -0.7% | -$2.43K | 0.24% | 87 |
|
|
2014
Q3 | $282K | Hold |
3,611
| – | – | 0.2% | 92 |
|
|
2014
Q2 | $228K | Buy |
3,611
+500
| +16% | +$31.6K | 0.15% | 98 |
|
|
2014
Q1 | $208K | Sell |
3,111
-3,111
| -50% | -$208K | 0.15% | 98 |
|
|
2013
Q4 | $399K | Buy |
+6,222
| New | +$399K | 0.28% | 78 |
|